Report Company Directory

Valmieras Stikla Skiedra

• AS VALMIERAS STIKLA ŠĶIEDRA izslēdz akcijas no Baltijas Otrā saraksta by GlobeNewsWire
• Delisting of AS VALMIERAS STIKLA ŠĶIEDRA shares from the Baltic Secondary List by GlobeNewsWire
• Par AS VALMIERAS STIKLA ŠĶIEDRA akciju izslēgšanu no regulētā tirgus by GlobeNewsWire
• Exclusion of AS VALMIERAS STIKLA ŠĶIEDRA shares from the regulated market by GlobeNewsWire
• Ievēlēta AS VALMIERAS STIKLA ŠĶIEDRA valde by GlobeNewsWire
• Election of the Management Board of VALMIERAS STIKLA ŠĶIEDRA AS by GlobeNewsWire
• Ziņojums par obligātā AS “VALMIERAS STIKLA ŠĶIEDRA” akciju atpirkšanas piedāvājuma rezultātiem by GlobeNewsWire
• Announcement of “VALMIERAS STIKLA ŠĶIEDRA” about the results of mandatory buyout offer by GlobeNewsWire
• Audited annual report of AS VALMIERAS STIKLA ŠĶIEDRA for 2020 by GlobeNewsWire
• Auditēts AS VALMIERAS STIKLA ŠĶIEDRA 2020. gada pārskats by GlobeNewsWire

VALMON INVERSIONES SIMCAV SA

Valmont Industries Inc.

• Tailwinds Include Data Centers, Highway Spending, Telecom Recovery … and Maybe Another Big Project in Egypt by William Blair
• Current Better Values List No. 294 by William Blair
• Valmont Industries, Inc.: Update to credit analysis following upgrade to Baa2 by Moody's Investors Service
• Valmont Industries, Inc. - September 2024 (LTM): Peer Snapshot by Moody's Investors Service
• Moody's Ratings upgrades Valmont Industries' senior unsecured rating to Baa2, outlook stable by Moody's Investors Service
• Valmont Industries Inc: 1 director by SmartInsider
• Potential Impact of Trump Administration Policies by William Blair
• Review of Third-Quarter Results by William Blair
• U.S. Consumer Sector "Group 2 - Consumer Private Company Compendium" Sole by UBS AG
• Third-Quarter First Look; Telecom Starting to Recover by William Blair

Valneva SE

Valneva SE

• Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference by GlobeNewsWire
• VALNEVA Declaration of shares and voting rights: December 31, 2024 by GlobeNewsWire
• Valneva pushing Ixchiq in Asia by Bryan Garnier
• Valneva accroît l’accessibilité de son vaccin contre le chikungunya en Asie grâce à une collaboration avec le Serum Institute of India by GlobeNewsWire
• Valneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of India by GlobeNewsWire
• VALNEVA - Declaration of shares and voting rights: November 30, 2024 by GlobeNewsWire
• Valneva annonce des données positives sur la persistance des anticorps à trois ans pour son vaccin à dose unique contre le chikungunya, IXCHIQ® by GlobeNewsWire
• Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ® by GlobeNewsWire
• Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA by GlobeNewsWire
• Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2 by GlobeNewsWire